Bristol-Myers Squibb
NYSE: BMY
$63.75
as on
Bristol-Myers Squibb Stock Performance
as on September 11, 2026 at 2:16 pm IST
Day's Low
Day's High
$63.74$64.64
0.02%
Downside
1.40%
Upside
52 Week's Low
52 Week's High
$42.52$68.6433.30%
Downside
7.67%
Upside
Bristol-Myers Squibb share price movements today
- Previous Close
- $64.41
- Open
- $64.64
- Volume
- 3.9M
- Market Cap
- $136.5B
- Dividend Yield
- 3.88%
- Day's Low - High
- $63.74 - $64.64
- 52 Week Low - High
- $42.52 - $68.64
Bristol-Myers Squibb Historical Returns
- 1 Month Return
- -0.66 %
- 3 Month Return
- + 15.85 %
- 1 Year Return
- + 36.61 %
- 3 Year Return
- + 5.9 %
- 5 Year Return
- + 2.03 %
Bristol-Myers Squibb Stock Fundamentals & Key Indicators
Check Bristol-Myers Squibb market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$136.5B
EPS (TTM)
4.54
Dividend Yield
3.88%
Quarterly Earnings Growth YOY
1.53%
PE Ratio (TTM)
14.19
Industry PE ratio
9.58
PEG Ratio
0.17232287525518436
EBITDA
16.7B
Revenue (TTM)
49.2B
Profit Margin
70.16%
Return On Equity TTM
46.75%
Bristol-Myers Squibb Stock Valuation
Track how Bristol-Myers Squibb P/E has moved over time to understand its valuation trends.
Bristol-Myers Squibb in the last 5 years
Lowest (-12.81x)
December 31, 2024
Industry (9.58x)
December 31, 2025
Today (15.59x)
December 31, 2025
Highest (24.22x)
December 31, 2022
Today’s Price to Earnings Ratio: 15.59x
Bristol-Myers Squibb vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Bristol-Myers Squibb with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| HOLD | $136.5B | 2.03% | 14.19 | 70.16% | 388% | |
| BUY | $1.1T | 369.4% | 37.66 | 84.01% | 59.45% | |
| BUY | $453.2B | 135.2% | 70.68 | 71.48% | 274.54% | |
| BUY | $663.3B | 59.96% | 30.88 | 70.45% | 196.19% | |
| BUY | $370.9B | 100.86% | 118.77 | 4.77% | 226.32% |
Stock Returns calculator for Bristol-Myers Squibb Stock including INR - Dollar returns
The Bristol-Myers Squibb stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Bristol-Myers Squibb investment value today
Current value as on today
₹1,46,533
Returns
₹46,533
(+46.53%)
Returns from Bristol-Myers Squibb Stock
₹35,207 (+35.21%)
Dollar Impact
₹11,327 (+11.33%)
Analyst Recommendation on Bristol-Myers Squibb Stock
Based on 19 analysts
42.11%
Buy
52.63%
Hold
5.26%
Sell
Based on 19 analysts, 52.63157894736842% of analysts recommend a 'HOLD' rating for Bristol-Myers Squibb. Average target price of $66.21
Bristol-Myers Squibb Share Price Target
Get share price movements and forecasts by analysts on Bristol-Myers Squibb.
What analysts predicted
3.72%UPSIDE
Target Price
$66.21
Current Price
$63.75
Analyzed by
19 Analysts
Target
$66.21
Bristol-Myers Squibb target price $66.21, a slight upside of 3.72% compared to current price of $63.75. According to 19 analysts rating.
Indian Investors' Interest in Bristol-Myers Squibb Stock
Search interest for Bristol-Myers Squibb Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Bristol-Myers Squibb Quarterly Profit & Loss
All numbers in Millions USD
Bristol-Myers Squibb Annual Profit & Loss
All numbers in Millions USD
Bristol-Myers Squibb Quarterly Cash Flow
All numbers in Millions USD
Bristol-Myers Squibb Annual Cash Flow
All numbers in Millions USD
Bristol-Myers Squibb News & Key Events
Today's Timeline - 10 September
Thu, 03:56 PM
-HSBC raises BMY price target to $65 from $60, maintaining a Hold rating.
Thu, 10:00 PM
-BMY completes long-term psoriasis study, providing data on deucravacitinib's safety and efficacy.
Thu, 10:00 PM
-BMY backs Phase 3 trial comparing chemotherapy with nivolumab for bladder cancer treatment.
Today's Timeline - 10 September
Thu, 10:01 PM
-BMY updates on ozanimod study against fingolimod for pediatric MS, aiming to expand market reach.
Fri, 03:15 AM
-Bristol Myers Squibb (BMY) declines 1.02%, underperforming the market; upcoming earnings forecast shows positive EPS and revenue growth.
Insights on Bristol-Myers Squibb
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Bristol-Myers Squibb Co. has shown positive revenue growth over the last two quarters. In the most recent quarter, the company's revenue increased from $11.48 billion to $12.97 billion, which represents an average growth of 11.4% per quarter.
- POSITIVE IMPACT
Profit Spike
Bristol-Myers Squibb Co. has shown strong financial performance in its net profit over the last three quarters. The company's net profit has increased from $1.08 billion to $3.31 billion, reflecting an average growth of 39.3% each quarter.
- POSITIVE IMPACT
Price Rise
In the last 3 months, BMY stock has moved up by 12.0%
NO EFFECTAgainst Peers
In the last 3 years, Eli Lilly & Co. has given 33.3% return, outperforming this stock by 28.5%
- NO EFFECT
Against Peers
In the last 1 year, Merck & Co., Inc. has given 69.9% return, outperforming this stock by 35.8%
About Bristol-Myers Squibb
| Organisation | Bristol-Myers Squibb |
| Headquarters | Route 206 & Province Line Road, Princeton, NJ, United States, 08543 |
| Industry | Drug Manufacturers - General |
| CEO | Dr. Christopher S. Boerner Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Bristol-Myers Squibb
Name | Title |
|---|---|
Ms. Ahn Amanda Poole | Executive VP & Chief People Officer |
Dr. Christopher S. Boerner Ph.D. | CEO & Chairman |
Mr. David V. Elkins | Executive VP & CFO |
Mr. Greg Meyers | Executive VP and Chief Digital & Technology Officer |
Mr. Adam Lenkowsky | Executive VP & Chief Commercialization Officer |
Mr. Cristian Massacesi M.D. | Executive VP, Chief Medical Officer & Head of Development |
Mr. Charles E. Triano | SVP & Head of Investor Relations |
Ms. Karin Shanahan | Executive VP, Chief Supply Chain & Operations Officer |
Ms. Cari Gallman | Executive VP, General Counsel & Chief Policy Officer |
Dr. Joseph J. Eiden Jr. | Head of Medical Affairs |
FAQs
What is Bristol-Myers Squibb share price today?
Bristol-Myers Squibb share price today is $63.75 as on at the close of the market. Bristol-Myers Squibb share today touched a day high of $64.64 and a low of $63.74.
What is the 52 week high and 52 week low for Bristol-Myers Squibb share?
Bristol-Myers Squibb share touched a 52 week high of $68.64 on and a 52 week low of $42.52 on . Bristol-Myers Squibb stock price today i.e. is closed at $63.75,which is 7.12% down from its 52 week high and 49.93% up from its 52 week low.
What is Bristol-Myers Squibb's market capitalisation today?
Bristol-Myers Squibb market capitalisation is $0.14T as on .
How to invest in Bristol-Myers Squibb Stock (BMY) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Bristol-Myers Squibb on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bristol-Myers Squibb Shares that will get you 0.0235 shares as per Bristol-Myers Squibb share price of $63.75 per share as on September 11, 2026 at 8:46 am IST.
What is the minimum amount required to buy Bristol-Myers Squibb Stock (BMY) from India?
Indian investors can start investing in Bristol-Myers Squibb (BMY) shares with as little as ₹95.43 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.30 in Bristol-Myers Squibb stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bristol-Myers Squibb share’s latest price of $63.75 as on September 11, 2026 at 8:46 am IST, you will get 0.1569 shares of Bristol-Myers Squibb. Learn more about
fractional shares .
What are the returns that Bristol-Myers Squibb has given to Indian investors in the last 5 years?
Bristol-Myers Squibb stock has given 2.03% share price returns and 28.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?